- Home
- CCEL vs SHLT Comparison
CCEL vs SHLT Comparison
Compare CCEL & SHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- SHLT
- Stock Information
- Founded
- CCEL 1989
- SHLT 1987
- Country
- CCEL United States
- SHLT Israel
- Employees
- CCEL N/A
- SHLT N/A
- Industry
- CCEL Managed Health Care
- SHLT Business Services
- Sector
- CCEL Health Care
- SHLT Consumer Discretionary
- Exchange
- CCEL Nasdaq
- SHLT Nasdaq
- Market Cap
- CCEL 50.0M
- SHLT 46.9M
- IPO Year
- CCEL 1997
- SHLT N/A
- Fundamental
- Price
- CCEL $7.40
- SHLT $2.88
- Analyst Decision
- CCEL
- SHLT Strong Buy
- Analyst Count
- CCEL 0
- SHLT 1
- Target Price
- CCEL N/A
- SHLT $11.00
- AVG Volume (30 Days)
- CCEL 13.7K
- SHLT 6.3K
- Earning Date
- CCEL 02-26-2025
- SHLT 09-26-2024
- Dividend Yield
- CCEL 3.38%
- SHLT N/A
- EPS Growth
- CCEL N/A
- SHLT N/A
- EPS
- CCEL N/A
- SHLT N/A
- Revenue
- CCEL $31,838,476.00
- SHLT $55,939,000.00
- Revenue This Year
- CCEL $3.97
- SHLT N/A
- Revenue Next Year
- CCEL $0.91
- SHLT N/A
- P/E Ratio
- CCEL N/A
- SHLT N/A
- Revenue Growth
- CCEL 1.95
- SHLT N/A
- 52 Week Low
- CCEL $4.47
- SHLT $2.54
- 52 Week High
- CCEL $9.50
- SHLT $8.14
- Technical
- Relative Strength Index (RSI)
- CCEL 46.30
- SHLT 49.41
- Support Level
- CCEL $6.74
- SHLT $2.69
- Resistance Level
- CCEL $7.50
- SHLT $3.21
- Average True Range (ATR)
- CCEL 0.42
- SHLT 0.21
- MACD
- CCEL -0.02
- SHLT -0.01
- Stochastic Oscillator
- CCEL 56.42
- SHLT 41.07
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from cellular processing and cryogenic storage and it derives revenue from processing and testing fees and storage segment.
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.